Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Initial risk assessment for pulmonary hypertension in patients with COPD.

Gartman EJ, Blundin M, Klinger JR, Yammine J, Roberts MB, Dennis McCool F.

Lung. 2012 Feb;190(1):83-9. doi: 10.1007/s00408-011-9346-8. Epub 2011 Nov 18.

PMID:
22094960
2.

[Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors].

Wang T, Mao Y, Sun Y, Hou W, Feng Y, Qu H.

Zhonghua Nei Ke Za Zhi. 2015 Dec;54(12):1037-40. Chinese.

PMID:
26887371
3.

Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.

Park JS, Lim HJ, Cho YJ, Lee JH, Yoon HI, Lee CT.

COPD. 2012 Aug;9(5):499-504. doi: 10.3109/15412555.2012.694922. Epub 2012 Sep 4.

PMID:
22946546
4.

Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).

Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K.

Osaka City Med J. 2011 Jun;57(1):21-9.

PMID:
22106764
5.

Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.

Holverda S, Bogaard HJ, Groepenhoff H, Postmus PE, Boonstra A, Vonk-Noordegraaf A.

Respiration. 2008;76(2):160-7. Epub 2007 Oct 25.

PMID:
17960052
6.
7.

Pulmonary hypertension in a stable community-based COPD population.

Fayngersh V, Drakopanagiotakis F, Dennis McCool F, Klinger JR.

Lung. 2011 Oct;189(5):377-82. doi: 10.1007/s00408-011-9315-2. Epub 2011 Aug 4.

PMID:
21814783
8.

Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease.

Zafar MA, Tsuang W, Lach L, Eschenbacher W, Panos RJ.

Lung. 2013 Apr;191(2):177-82. doi: 10.1007/s00408-012-9443-3. Epub 2013 Jan 3.

PMID:
23283384
9.

Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia.

Lee JH, Oh YM, Seo JB, Lee YK, Kim WJ, Sheen SS, Kim TH, Lee JH, Kim EK, Lee JS, Huh JW, Lim SY, Yoon HI, Shin TR, Lee SM, Lee SY, Lee SD.

Int J Tuberc Lung Dis. 2011 Jun;15(6):830-7. doi: 10.5588/ijtld.10.0598.

PMID:
21575307
10.

Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.

Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF.

Arch Phys Med Rehabil. 2010 Feb;91(2):221-5. doi: 10.1016/j.apmr.2009.10.017.

PMID:
20159125
11.

[Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].

Chlumský J, Stĕrbová L, Smolíková L, Matous M, Salajka F.

Vnitr Lek. 2002 Apr;48(4):320-4. Czech.

PMID:
12061182
12.

Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.

Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, Videbaek R, Carlsen J.

J Heart Lung Transplant. 2012 Apr;31(4):373-80. doi: 10.1016/j.healun.2011.11.020. Epub 2012 Jan 9.

PMID:
22226804
13.

[Effect of lung transplantation on pulmonary function in 5 patients with chronic obstructive pulmonary disease].

Liu JM, Yang WL, Jiang GN, Ding JA, Wang YM, Zheng W, Zhu D, Gao BL, Jiang P, Wu W.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Aug;28(8):509-12. Chinese.

PMID:
16207394
14.

Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD.

Vonbank K, Funk GC, Marzluf B, Burian B, Ziesche R, Stiebellehner L, Petkov V, Haber P.

Wien Klin Wochenschr. 2008;120(23-24):749-55. doi: 10.1007/s00508-008-1103-5.

PMID:
19122986
15.

Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.

Yilmaz R, Gencer M, Ceylan E, Demirbag R.

J Am Soc Echocardiogr. 2005 Aug;18(8):873-81.

PMID:
16084341
16.

[Efficacy of the 6-minute walk test in evaluating ambulatory oxygen therapy].

Morante F, Güell R, Mayos M.

Arch Bronconeumol. 2005 Nov;41(11):596-600. Spanish.

17.

Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg.

García-Talavera I, García CH, Macario CC, de Torres JP, Celli BR, Aguirre-Jaime A.

Respir Med. 2008 Jul;102(7):1026-32. doi: 10.1016/j.rmed.2008.02.004. Epub 2008 Mar 17.

18.

Aerobic exercise capacity in COPD patients with and without pulmonary hypertension.

Pynnaert C, Lamotte M, Naeije R.

Respir Med. 2010 Jan;104(1):121-6. doi: 10.1016/j.rmed.2009.06.006. Epub 2009 Jul 3.

19.

Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.

Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.

Clin Ther. 2011 Dec;33(12):1974-84. doi: 10.1016/j.clinthera.2011.11.009.

PMID:
22177371
20.

Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease.

Hill K, Jenkins SC, Cecins N, Philippe DL, Hillman DR, Eastwood PR.

Arch Phys Med Rehabil. 2008 Sep;89(9):1782-7. doi: 10.1016/j.apmr.2008.01.020.

PMID:
18760164

Supplemental Content

Support Center